| A Study of NPC-22 in Healthy Adult Males (NCT04203862) | Nobelpharma | 2019-11-19 |
| Exploratory Study of IMM01 for Injection in the Treatment of Refractory or Recurrent Hematologic Malignancy (NCT05860075) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2019-11-19 |
| The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans (NCT04126707) | Ascentage Pharma Group Inc. | 2019-11-19 |
| A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan in Healthy Volunteers (NCT04156646) | Hoffmann-La Roche | 2019-11-19 |
| Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma (NCT04250324) | Shanghai Cell Therapy Group Co.,Ltd | 2019-11-19 |
| Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 Pharmacokinetics (NCT04137055) | Guangdong Raynovent Biotech Co., Ltd | 2019-11-19 |
| Renal PK Study of LC350189 (NCT04066712) | LG Chem | 2019-11-19 |
| Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma (NCT04019002) | Susan Chang | 2019-11-19 |
| Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia (NCT03844815) | University of Chicago | 2019-11-18 |
| Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim (NCT04171739) | F2G Ltd | 2019-11-18 |
| A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies (NCT04014205) | Beijing InnoCare Pharma Tech Co., Ltd. | 2019-11-18 |
| A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer (NCT04179864) | Epizyme, Inc. | 2019-11-18 |
| A Study of LY900014 in Healthy Chinese Participants (NCT04049123) | Eli Lilly and Company | 2019-11-18 |
| Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium (NCT04189666) | Ain Shams University | 2019-11-18 |
| Glumetinib Combined With Osimertinib in the Treatment of Relapsed and Metastatic Non-small Cell Lung Cancer Patients Who Failed to Receive EGFR Inhibitors (NCT04338243) | Haihe Biopharma Co., Ltd. | 2019-11-18 |
| A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC) (NCT04073615) | Elevar Therapeutics | 2019-11-18 |
| Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma (NCT03854474) | National Cancer Institute (NCI) | 2019-11-18 |
| Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound (NCT04235296) | Chinese PLA General Hospital | 2019-11-17 |
| The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers (NCT05152017) | St. Petersburg Research Institute of Vaccines and Sera | 2019-11-16 |
| Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers (NCT04098263) | Lumen Bioscience, Inc. | 2019-11-15 |
| HDM201 Added to CT in R/R or Newly Diagnosed AML (NCT03760445) | Novartis Pharmaceuticals | 2019-11-15 |
| Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine (NCT03961438) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2019-11-15 |
| Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy (NCT03619655) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-11-15 |
| Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fasting Conditions (NCT04411940) | Cycle Pharmaceuticals Ltd. | 2019-11-15 |
| A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants (NCT04175925) | Bristol-Myers Squibb | 2019-11-15 |
| Levobupivacaine vs Levobupivacaine + Dexmedetomidine Infiltration for Post-tonsillectomy Analgesia and Laryngospasm in Pediatric Patients (NCT04113720) | Assiut University | 2019-11-15 |
| Stem Cell Transplantation in Crohn's Disease (NCT04224558) | Cedars-Sinai Medical Center | 2019-11-15 |
| The Bispecific PSMAxCD3 Antibody CC-1 in Patients with Castration Resistant Prostate Carcinoma (NCT04104607) | University Hospital Tuebingen | 2019-11-15 |
| Healthy Heart Habits (NCT04158219) | Hennepin Healthcare Research Institute | 2019-11-15 |
| BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) (NCT04044001) | Michael Hoelscher | 2019-11-15 |
| Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fed Conditions (NCT04411953) | Cycle Pharmaceuticals Ltd. | 2019-11-15 |
| A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors (NCT04128085) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-11-15 |
| A Study to Explore Pharmacodynamic Effects of BIIB104 on Brain Circuitry in Healthy Participants (NCT04068532) | Biogen | 2019-11-15 |
| BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC (NCT03791398) | Brown University | 2019-11-15 |
| Clinical Study of Intra Articular Injection of Catholic MASTER Cell (Bone Marrow Derived Mesenchymal Stem Cell) in Knee Osteoarthritis (NCT04240873) | Seoul St. Mary's Hospital | 2019-11-15 |
| Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic Impairment (NCT04145596) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2019-11-14 |
| Safety and IOP-Lowering Effects of WB007 (NCT04149899) | Bausch & Lomb Incorporated | 2019-11-14 |
| A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants (NCT05581758) | Amgen | 2019-11-14 |
| Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer (NCT04115306) | Phoenix Molecular Designs | 2019-11-14 |
| A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma (NCT04047251) | Fujifilm Pharmaceuticals U.S.A., Inc. | 2019-11-14 |
| Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults (NCT04175808) | Cytokinetics | 2019-11-14 |
| Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease (NCT03998423) | University of Wisconsin, Madison | 2019-11-14 |
| A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants (NCT04155567) | Takeda | 2019-11-13 |
| A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT) (NCT04105335) | Mina Alpha Limited | 2019-11-13 |
| Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. (NCT04152018) | Pfizer | 2019-11-13 |
| Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ® (NCT04905667) | Genor Biopharma Co., Ltd. | 2019-11-13 |
| Topical Silver Nanoparticles for Microbial Activity (NCT03752424) | Ahmed A. H. Abdellatif | 2019-11-13 |
| A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients (NCT03821272) | University of Arkansas | 2019-11-13 |
| A Study of Lasmiditan in Healthy Chinese Participants (NCT04081324) | Eli Lilly and Company | 2019-11-13 |
| The the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XNW3009 in Health Subject (NCT04040907) | Evopoint Biosciences Inc. | 2019-11-13 |
| Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects (NCT04171310) | Sanofi | 2019-11-13 |
| Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants (NCT05550129) | Amgen | 2019-11-13 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2 (NCT03580278) | Affibody | 2019-11-13 |
| A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants (NCT05254613) | Alexion Pharmaceuticals, Inc. | 2019-11-12 |
| Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine (NCT04138615) | University of Texas Southwestern Medical Center | 2019-11-12 |
| BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG (NCT04478357) | Pfizer | 2019-11-12 |
| Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer (NCT04042051) | Cancer Trials Ireland | 2019-11-12 |
| Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer (NCT04182724) | Chinese PLA General Hospital | 2019-11-12 |
| Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol (NCT04145375) | Zenith Epigenetics | 2019-11-12 |
| A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation (NCT04176393) | CStone Pharmaceuticals | 2019-11-12 |
| First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. (NCT04097002) | Orca Therapeutics B.V. | 2019-11-12 |
| Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease (DREPAGLOBE) (NCT03964792) | Assistance Publique - Hôpitaux de Paris | 2019-11-12 |
| Study of MT-5111 in HER2-positive Solid Tumors (NCT04029922) | Molecular Templates, Inc. | 2019-11-12 |
| Tuberculosis Clinical Trials Consortium Study 35 (NCT03730181) | Centers for Disease Control and Prevention | 2019-11-12 |
| PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS (NCT04104451) | University of Colorado, Denver | 2019-11-12 |
| A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 (NCT04166669) | Basilea Pharmaceutica | 2019-11-12 |
| Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer (NCT04085315) | Collin Blakely | 2019-11-12 |
| A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma (NCT04162015) | Memorial Sloan Kettering Cancer Center | 2019-11-12 |
| Clinical Study of GH001 in Depression (NCT04698603) | GH Research Ireland Limited | 2019-11-12 |
| Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD) (NCT04175132) | H. Lundbeck A/S | 2019-11-12 |
| Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis (NCT04205851) | Kinevant Sciences GmbH | 2019-11-12 |
| Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN (NCT04034225) | Sensei Biotherapeutics, Inc. | 2019-11-11 |
| Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer (NCT04131192) | Sunshine Lake Pharma Co., Ltd. | 2019-11-11 |
| Preemptive Oral Gabapentin 600 mg in Reducing Morphine Requirement After Non Obstetric Lower Abdominal Surgery (NCT04434430) | Indonesia University | 2019-11-11 |
| A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy Volunteers (NCT03881163) | Zambon SpA | 2019-11-11 |
| Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors (NCT04140500) | Hoffmann-La Roche | 2019-11-11 |
| Study of DF1001 in Patients With Advanced Solid Tumors (NCT04143711) | Dragonfly Therapeutics | 2019-11-11 |
| A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250 (NCT04201080) | Trevena Inc. | 2019-11-11 |
| The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man (NCT04143750) | Jiangsu vcare pharmaceutical technology co., LTD | 2019-11-11 |
| TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects (NCT04168723) | MedDay Pharmaceuticals SA | 2019-11-11 |
| Drug-Drug Interaction Study of "CG-651" in Healthy Volunteer (NCT05370716) | CrystalGenomics, Inc. | 2019-11-11 |
| Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer (NCT04231552) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2019-11-10 |
| Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing (NCT03433833) | University of Illinois at Chicago | 2019-11-10 |
| Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion (NCT04340284) | Dr. Himanshu Bansal Foundation | 2019-11-10 |
| Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product (NCT04193852) | Laboratorios Andromaco S.A. | 2019-11-09 |
| Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers (NCT03816332) | National Cancer Institute (NCI) | 2019-11-08 |
| A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm (NCT04041050) | AbbVie | 2019-11-08 |
| HDDO-1801 Intervention Trial (NCT04097951) | Hyundai Pharmaceutical Co., LTD. | 2019-11-08 |
| A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants (NCT05988034) | Amgen | 2019-11-08 |
| Study of Aldafermin (NGM282) in Participants With Impaired Renal Function (NCT04179630) | NGM Biopharmaceuticals, Inc | 2019-11-08 |
| A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole (NCT04121910) | AstraZeneca | 2019-11-07 |
| Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects (NCT04158102) | Nuance Pharma (shanghai) Co., Ltd | 2019-11-07 |
| Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer (NCT04046575) | Washington University School of Medicine | 2019-11-07 |
| Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment (NCT04154670) | Ensoma | 2019-11-07 |
| Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers (NCT04134143) | Stratatech, a Mallinckrodt Company | 2019-11-07 |
| Mental Effects of Analgesic Drugs: Paracetamol and Ibuprofen (NCT04424420) | Prof. Jürgen Brockmöller | 2019-11-07 |
| A Study of Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal Hepatic Function (NCT04154774) | Janssen Research & Development, LLC | 2019-11-07 |
| Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression (NCT04180371) | BicycleTx Limited | 2019-11-07 |
| Study of Safety and Immunogenicity of BVRS-GamVac (NCT04130594) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-11-07 |
| A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity (NCT04415346) | Huons Co., Ltd. | 2019-11-06 |